The Supreme Court has stayed an execution in Alabama, marking a rare reversal in the justices' typically aggressive stance toward blocking stays of death sentences. This decision represents the first time in over five years that the current Court majority refused to overturn a lower court's execution hold.
The case centers on the method of execution. Alabama planned to use nitrogen hypoxia, an execution technique never used before in the United States. The condemned inmate challenged the method as potentially violating the Eighth Amendment's ban on cruel and unusual punishment.
Lower courts blocked the execution, citing unresolved questions about whether nitrogen hypoxia would cause unnecessary pain. Rather than immediately lifting that block, the Supreme Court allowed it to stand, at least temporarily. This breaks from the Court's recent pattern of clearing the way for executions to proceed despite legal challenges.
The decision reflects deep divisions on the Court over execution methods. Conservative justices have generally moved to expedite executions and limit inmates' legal avenues for challenging sentences. Liberal justices argue that novel execution techniques require rigorous testing and evidence about their safety.
Nitrogen hypoxia proponents claim the method is painless, involving a nitrogen-filled mask that causes unconsciousness before death. Critics worry about malfunction and the lack of any track record in actual executions. No state has successfully carried out this method.
The Court's temporary hold signals potential openness to arguments about execution protocols, though it does not indicate the justices will ultimately block the execution. The case highlights ongoing tensions between the Court's death penalty jurisprudence and evolving questions about how states carry out capital sentences.
The stay affects not just Alabama but other states considering nitrogen hypoxia. Oklahoma and Alabama both have expressed interest in the method as an alternative to lethal injection, which has faced mounting legal challenges over drug supplies and administration problems.